{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:16:28Z","timestamp":1782497788425,"version":"3.54.5"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007779","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000}}],"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007779","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T17:44:43Z","timestamp":1569433483000},"page":"e0007779","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt"],"prefix":"10.1371","volume":"13","author":[{"given":"Haidi Karam-Allah","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed Attia","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed Ahmed","family":"Elossily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-3122","authenticated-orcid":true,"given":"Alzahraa Abdelraouf","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan Ahmed","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Soliman","family":"Abd- Elkader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3334-0645","authenticated-orcid":true,"given":"Eman M. Nagiub","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0586-1526","authenticated-orcid":true,"given":"Hani M. J.","family":"Khojah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"pntd.0007779.ref001","unstructured":"World Health Organization. Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control. WHO headquarters, Geneva, Switzerland, 17\u201318 October 2006. Geneva: WHO, 2007; https:\/\/www.who.int\/neglected_diseases\/preventive_chemerapy\/WHO_CDS_NTD_PCT_2007.1.pdf."},{"key":"pntd.0007779.ref002","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ijpara.2005.07.010","article-title":"Fascioliasis and other plant-borne trematode zoonoses","volume":"35","author":"S Mas-Coma","year":"2005","journal-title":"Int J Parasitol"},{"key":"pntd.0007779.ref003","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(11)70294-8","article-title":"Global burden of human food-borne trematodiasis: A systematic review and meta-analysis","volume":"12","author":"T Furst","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"pntd.0007779.ref004","first-page":"317","article-title":"A review on fascioliasis in Egypt","volume":"32","author":"AN Haseeb","year":"2002","journal-title":"J Egypt Soc Parasitol"},{"key":"pntd.0007779.ref005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4269\/ajtmh.2003.69.429","article-title":"Hyperendemic fascioliasis associated with schistosomiasis in villages in the Nile delta of Egypt","volume":"69","author":"JG Esteban","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0007779.ref006","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(96)10221-X","article-title":"Disease in Egyptian mummies: The contribution of new technologies","volume":"349","author":"AR David","year":"1997","journal-title":"Lancet"},{"key":"pntd.0007779.ref007","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4067\/S0717-77122003000300015","article-title":"Fasciola hepatica infection in cattle and buffaloes in the state of Rio Grande do Sul, Brazil","volume":"58","author":"SM Tietz Marques","year":"2003","journal-title":"Parasitolog\u00eda latinoamericana"},{"key":"pntd.0007779.ref008","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/pim.12343","article-title":"A prospective view of animal and human fasciolosis","volume":"38","author":"K Cwiklinski","year":"2016","journal-title":"Parasite Immunol"},{"key":"pntd.0007779.ref009","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.pt.2016.03.002","article-title":"Current threat of triclabendazole resistance in fasciola hepatica","volume":"32","author":"JM Kelley","year":"2016","journal-title":"Trends Parasitol"},{"key":"pntd.0007779.ref010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2036.2003.01419.x","article-title":"Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru","volume":"17","author":"L Favennec","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"pntd.0007779.ref011","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1517\/13543784.14.12.1513","article-title":"Triclabendazole for the treatment of fascioliasis and paragonimiasis","volume":"14","author":"J Keiser","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"pntd.0007779.ref012","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/QCO.0000000000000482","article-title":"Recent developments in the epidemiology, diagnosis, and treatment of fasciola infection","volume":"31","author":"CM Webb","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"pntd.0007779.ref013","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3201\/eid1806.120302","article-title":"Apparent triclabendazole-resistant human fasciola hepatica infection, the Netherlands","volume":"18","author":"AJ Winkelhagen","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"pntd.0007779.ref014","first-page":"1330","article-title":"Resistant human fasciolasis: Report of four patients","volume":"142","author":"LC Gil","year":"2014","journal-title":"Rev Med Chil"},{"key":"pntd.0007779.ref015","first-page":"27","article-title":"Partial hepatectomy for the resistant fasciola hepatica infection in a child","volume":"6","author":"G Belgin","year":"2015","journal-title":"APSP J Case Rep"},{"key":"pntd.0007779.ref016","doi-asserted-by":"crossref","first-page":"e0004361","DOI":"10.1371\/journal.pntd.0004361","article-title":"Treatment failure after multiple courses of triclabendazole among patients with fascioliasis in Cusco, Peru: A case series","volume":"10","author":"MM Cabada","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007779.ref017","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1128\/AAC.00828-10","article-title":"In vivo and in vitro sensitivity of fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78","volume":"54","author":"U Duthaler","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0007779.ref018","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpddr.2014.07.002","article-title":"Repurposing drugs for the treatment and control of helminth infections","volume":"4","author":"G Panic","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"pntd.0007779.ref019","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/JCM.13.5.882-884.1981","article-title":"Comparison of formalin-ethyl ether sedimentation, formalin-ethyl acetate sedimentation, and zinc sulfate flotation techniques for detection of intestinal parasites","volume":"13","author":"AL Truant","year":"1981","journal-title":"J Clin Microbiol"},{"key":"pntd.0007779.ref020","unstructured":"Fascioliasis diagnosis, treatment and control strategy. World Health Organization. https:\/\/www.who.int\/foodborne_trematode_infections\/fascioliasis\/fascioliasis_diagnosis\/en\/."},{"key":"pntd.0007779.ref021","doi-asserted-by":"crossref","first-page":"888","DOI":"10.26719\/1999.5.5.888","article-title":"Triclabendazole in the treatment of human fascioliasis: A community-based study","volume":"5","author":"H el-Morshedy","year":"1999","journal-title":"East Mediterr Health J"},{"key":"pntd.0007779.ref022","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/tropej\/45.3.135","article-title":"Human fascioliasis in Egyptian children: Successful treatment with triclabendazole","volume":"45","author":"H el-Karaksy","year":"1999","journal-title":"J Trop Pediatr"},{"key":"pntd.0007779.ref023","first-page":"137","article-title":"Therapeutic effect of triclabendazole in patients with fascioliasis in Egypt: A preliminary study","volume":"25","author":"NA Hammouda","year":"1995","journal-title":"J Egypt Soc Parasitol"},{"key":"pntd.0007779.ref024","first-page":"OE05","article-title":"Immunodiagnosis of human fascioliasis: An update of concepts and performances of the serological assays","volume":"11","author":"B Sarkari","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"pntd.0007779.ref025","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1017\/S0031182014000869","article-title":"Diagnosis of human fascioliasis by stool and blood techniques: Update for the present global scenario","volume":"141","author":"S Mas-Coma","year":"2014","journal-title":"Parasitology"},{"key":"pntd.0007779.ref026","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4269\/ajtmh.2008.78.388","article-title":"A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam","volume":"78","author":"TT Hien","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0007779.ref027","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4269\/ajtmh.15-0030","article-title":"Human fascioliasis: A re-emerging disease in Upper Egypt","volume":"93","author":"MA Mekky","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0007779.ref028","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/QCO.0b013e32830f9818","article-title":"Update on hepatobiliary flukes: Fascioliasis, opisthorchiasis and clonorchiasis","volume":"21","author":"LA Marcos","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"pntd.0007779.ref029","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/tropej\/43.3.162","article-title":"Human fascioliasis: Clinical features and diagnostic difficulties in Egyptian children","volume":"43","author":"M el-Shabrawi","year":"1997","journal-title":"J Trop Pediatr"},{"key":"pntd.0007779.ref030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4269\/ajtmh.2008.78.222","article-title":"Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis","volume":"78","author":"LA Marcos","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0007779.ref031","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/expr.2000.4501","article-title":"Fasciola hepatica: Influence of gender and liver biotransformations on flukicide treatment efficacy of rats infested and cured with either clorsulon\/ivermectin or triclabendazole","volume":"94","author":"P Sibille","year":"2000","journal-title":"Exp Parasitol"},{"key":"pntd.0007779.ref032","doi-asserted-by":"crossref","first-page":"e71520","DOI":"10.1371\/journal.pone.0071520","article-title":"An outbreak of human fascioliasis gigantica in southwest China","volume":"8","author":"JX Chen","year":"2013","journal-title":"PLoS One"},{"key":"pntd.0007779.ref033","first-page":"455","volume":"30","author":"W Gu","year":"2012","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"pntd.0007779.ref034","first-page":"447","article-title":"Testing the parasiticidal efficacy of nitazoxanide","volume":"13","author":"MS Abdel-Rahman","year":"1997","journal-title":"Alex J Vet Sci"},{"key":"pntd.0007779.ref035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0011-393X(00)80003-X","article-title":"An open-label clinical study of nitazoxanide in the treatment of human fascioliasis","volume":"61","author":"SM Kabil","year":"2000","journal-title":"Curr Ther Res Clin Exp"},{"key":"pntd.0007779.ref036","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0035-9203(98)90974-9","article-title":"Successful treatment of human fascioliasis with nitazoxanide","volume":"92","author":"JF Rossignol","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0007779.ref037","doi-asserted-by":"crossref","first-page":"e2553","DOI":"10.1371\/journal.pntd.0002553","article-title":"Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla state, Mexico: Epidemiology and treatment with nitazoxanide","volume":"7","author":"JL Zumaquero-Rios","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007779.ref038","unstructured":"del Risco Barrios U, V\u00e1zquez Drake CT, Garc\u00eda Gonz\u00e1lez G, Sanch\u00e9n Casas A. Evaluaci\u00f3n de la excreci\u00f3n de huevos de fasciola hep\u00e1tica por tres esquemas terap\u00e9uticos. 2001;5. Disponible en: http:\/\/scielo.sld.cu\/scielo.php?script=sci_arttext&pid=S1025-02552001000400002&lng=es."},{"key":"pntd.0007779.ref039","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yexmp.2007.01.009","article-title":"Understanding triclabendazole resistance","volume":"82","author":"GP Brennan","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"pntd.0007779.ref040","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1017\/S0031182013000759","article-title":"ncreased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil","volume":"140","author":"M Meaney","year":"2013","journal-title":"Parasitology"},{"key":"pntd.0007779.ref041","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molbiopara.2014.11.006","article-title":"The T687G SNP in a P-glycoprotein gene of Fasciola hepatica is not associated with resistance to triclabendazole in two resistant Australian populations","volume":"198","author":"TP Elliott","year":"2014","journal-title":"Mol Biochem Parasitol"},{"key":"pntd.0007779.ref042","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bmcl.2016.12.004","article-title":"Novel triclabendazole prodrug: A highly water soluble alternative for the treatment of fasciolosis","volume":"27","author":"M Flores-Ramos","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"pntd.0007779.ref043","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/tvjl.1999.0377","article-title":"Fasciolicides: Efficacy, actions, resistance and its management","volume":"158","author":"I Fairweather","year":"1999","journal-title":"Vet J"},{"key":"pntd.0007779.ref044","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-4017(00)00413-1","article-title":"An experimental study on triclabendazole resistance of Fasciola hepatica in sheep","volume":"95","author":"CP Gaasenbeek","year":"2001","journal-title":"Vet Parasitol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007779","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000}},{"DOI":"10.1371\/journal.pntd.0008443","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T22:31:49Z","timestamp":1664490709000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007779"}},"subtitle":[],"editor":[{"given":"John Pius","family":"Dalton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007779","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pntd.0008443","asserted-by":"object"}],"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0007779","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]}}}